Mebias Discovery

Focus: Mebias Discovery is an early-stage biotech focused on GPCR drug discovery and diagnostics, headquartered in Philadelphia with a single Phase 1 program in pain management.

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About Mebias Discovery

AI assessmentNot Hiring

No open roles listed right now. Follow Mebias Discovery to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

1 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

MEB-1170

Pain

Phase 1

Clinical Trials (1)

NCT05748119A Study to Assess the Safety of MEB-1170 in Healthy Subjects

Phase 1

Help build intelligence for Mebias Discovery

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to contribute to novel GPCR-targeted therapeutics in an underpenetrated modality with significant unmet need in pain management
Early-stage environment offers hands-on involvement in drug discovery and clinical development from Phase 1 onwards
Philadelphia biotech ecosystem provides networking and talent density advantages

Watch Out For

Company has zero active job openings, indicating no current hiring and potential resource constraints or stalled growth
Extremely early pipeline (1 Phase 1 program) with no revenue, publications, or financial data raises questions about scientific validation and funding runway
Minimal public presence, no disclosed funding history, and lack of employee count data suggest limited operational scale or transparency

Generated by Claude from Mebias Discovery's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2019

Portfolio: 1 clinical trial

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo